Mode
Text Size
Log in / Sign up

Mechanopriming by vascular stiffness and disturbed flow drive pathological reprogramming in atherosclerosisMechanisms of Vascular Stiffness Link to Atherosclerosis Development

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that mechanopriming by stiffness and flow drives cellular reprogramming but lacks clinical trial validation.

This narrative review synthesizes the role of mechanical forces in atherosclerosis, specifically focusing on mechanopriming by vascular stiffness and phenotypic reprogramming caused by disturbed flow (DF) and oscillatory shear stress (OSS). The authors describe how Piezo1 ion channels and 5-HT1B receptors act as coincidence detectors to integrate fluid shear stress and matrix stiffness, subsequently activating YAP and c-REL.

The review details how the dysregulation of these mechanopathways leads to pathological reprogramming, including senescence, pyroptosis, and endothelial-to-mesenchymal transition (EndoMT). Additionally, it highlights impaired RBPJ-epigenetically regulated macrophage efferocytosis and pathological matrix remodeling by smooth muscle cells and fibroblasts.

While the review proposes a novel precision cardiovascular medicine framework incorporating hemodynamic parameters into risk stratification, it notes that current research has limitations. The discussion of mechanodrugs and stent optimization is theoretical; no clinical trial data or evidence of efficacy for these specific interventions are provided.

How this fits prior evidence

This narrative review extends prior findings regarding the influence of mechanical shear stress on endothelial RNA methylation in atherosclerosis. It further expands upon the role of vascular smooth muscle cell immune interactions as a mechanism driving remodeling across cardiovascular diseases, though it focuses specifically on how those cells contribute to pathological matrix remodeling under mechanical stress.

This review looks at how mechanical forces, such as the stiffness of blood vessels and the way blood flows through them, affect heart health. Researchers identified specific sensors in the body that detect these physical stresses. When these systems are disrupted, they can trigger harmful changes in cells, including aging and cell death.

The study highlights how these physical signals lead to issues like damaged vessel linings and abnormal tissue growth. These processes contribute to atherosclerosis, a condition where arteries narrow over time. The research focuses on the underlying biological pathways that turn mechanical stress into cellular damage.

Because this is a narrative review of theoretical mechanisms, it does not provide data from human clinical trials. It explores how future treatments might target these physical signals rather than just chemical ones. Patients should consult their doctors to discuss current heart health management and any new treatment options.

What this means for you:
Physical forces like vessel stiffness and blood flow patterns play a role in the development of atherosclerosis.

Common questions

What role does blood flow play in heart health?

The study describes how disturbed flow and oscillatory shear stress can cause cells to change. When these mechanical signals are disrupted, it can trigger pathways that lead to cell aging and death. These changes contribute to the development of atherosclerosis.

How does vessel stiffness affect the heart?

Vessel stiffness acts as a signal for certain sensors in the body. When these sensors detect high stiffness combined with poor blood flow, they can activate pathways that lead to pathological remodeling of tissue and damage to the inner lining of the arteries.

Are there new drugs being developed for these issues?

The review discusses the concept of 'mechanodrugs' and improved stents as future possibilities. However, this research is a theoretical review and does not provide evidence that these specific treatments are currently available or effective in clinical practice.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Atherosclerosis exhibits a distinct focal distribution at arterial bifurcations and curvatures, underscoring that systemic risk factors alone are insufficient to fully elucidate its pathogenesis. The coupling of local fluid shear stress—particularly disturbed flow (DF) and oscillatory shear stress (OSS)—with vascular wall stiffness constitutes the core mechanical driver of site-specific plaque progression. This narrative review systematically elucidates the cutting-edge molecular mechanisms of vascular wall-mediated “mechanopriming” and endothelial mechanotransduction. We highlight how the Piezo1 ion channel and the 5-HT1B receptor act as “coincidence detectors,” precisely integrating fluid shear stress and matrix stiffness signals to subsequently activate central signaling hubs such as YAP and c-REL. The dysregulation of these mechanopathways not only triggers pathological reprogramming of endothelial cells—including cGAS-STING-mediated deep senescence, NLRP3-driven pyroptosis, and endothelial-to-mesenchymal transition (EndoMT)—but also impairs RBPJ-epigenetically regulated macrophage efferocytosis and drives pathological matrix remodeling by smooth muscle cells and fibroblasts via complex transcellular communication networks. Clinically, the fusion of multimodal imaging with computational fluid dynamics (CFD), alongside emerging ultrafast ultrasound vector flow imaging, has pioneered novel avenues for the high-fidelity in vivo quantification of wall shear stress (WSS). Finally, we critically evaluate current research limitations and prospectively discuss frontier shear stress-targeted therapeutic strategies—such as “mechanodrugs,” biomimetic nanodelivery, and hemodynamic stent optimization—proposing a novel precision cardiovascular medicine framework that formally incorporates localized hemodynamic parameters into established clinical risk stratification algorithms like the ASCVD and SCORE2 models.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.